Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-05-01 @ 1:38 AM
Study NCT ID:
NCT01220258
Status:
TERMINATED
Last Update Posted:
2013-12-16
First Post:
2010-10-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Posterior Blepharoconjunctivitis | View |
Keywords: